These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid]. Malchow H Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152 [No Abstract] [Full Text] [Related]
13. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission. Eliakim R; Wengrower D; Ligumsky M; Rachmilewitz D Isr J Med Sci; 1990 Jan; 26(1):47-9. PubMed ID: 1968895 [No Abstract] [Full Text] [Related]
14. Sulphasalazine in inflammatory bowel disease: recent advances. Cooper BT N Z Med J; 1986 Oct; 99(811):757-9. PubMed ID: 2877428 [No Abstract] [Full Text] [Related]
15. 5-aminosalicylic acid as rectal enema in ulcerative colitis patients unable to take sulphasalazine. Campieri M; Lanfranchi GA; Brignola C; Bazzocchi G; Minguzzi MR; Calari MT Lancet; 1984 Feb; 1(8373):403. PubMed ID: 6141471 [No Abstract] [Full Text] [Related]
16. Mesalamine for ulcerative colitis. Med Lett Drugs Ther; 1988 May; 30(766):53-4. PubMed ID: 3283508 [No Abstract] [Full Text] [Related]
18. Will there be a next generation of sulfasalazine? Goldman P Gastroenterology; 1982 Nov; 83(5):1138-41. PubMed ID: 6126420 [No Abstract] [Full Text] [Related]